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Clostridium difﬁcile is an anaerobic Gram-positive bacterium that causes intestinal infections with symptoms ranging from
mild diarrhea to fulminant colitis. Cyclic diguanosine monophosphate (c-di-GMP) is a bacterial second messenger that typically
regulates the switch from motile, free-living to sessile and multicellular behaviors in Gram-negative bacteria. Increased intracel-
lular c-di-GMP concentration in C. difﬁcile was recently shown to reduce ﬂagellar motility and to increase cell aggregation. In
this work, we investigated the role of the primary type IV pilus (T4P) locus in c-di-GMP-dependent cell aggregation. Inactivation
of two T4P genes, pilA1 (CD3513) and pilB1 (CD3512), abolished pilus formation and signiﬁcantly reduced cell aggregation un-
der high c-di-GMP conditions. pilA1 is preceded by a putative c-di-GMP riboswitch, predicted to be transcriptionally active
upon c-di-GMP binding. Consistent with our prediction, high intracellular c-di-GMP concentration increased transcript levels
of T4P genes. In addition, single-round in vitro transcription assays conﬁrmed that transcription downstream of the predicted
transcription terminator was dose dependent and speciﬁc to c-di-GMP binding to the riboswitch aptamer. These results support
a model in which T4P gene transcription is upregulated by c-di-GMP as a result of its binding to an upstream transcriptionally
activating riboswitch, promoting cell aggregation in C. difﬁcile.
The Gram-positive spore-forming bacterium Clostridium difﬁ-cile is the leading cause of nosocomial diarrhea and antibiotic-
associated colitis in hospital settings (1). Illness caused by C.
difﬁcile infections (CDI) may range from mild diarrhea to life-
threatening, fulminant colitis. Throughout its life cycle, C. difﬁcile
has to cope with multiple changing environments. In the early
steps of CDI, in order to colonize the colon and produce toxins,C.
difﬁcile spores ﬁrst germinate in the intestine in response to stim-
uli such as the presence of bile salts (2, 3). Vegetative cells need to
reach the colon, likely attaching to and colonizing the gutmucosa,
where they proliferate and produce toxins. Hence, C. difﬁcile ar-
guably needs to sense and integrate multiple environmental stim-
uli in order to coordinate the expression of its colonization and
virulence factors during its journey through the gastrointestinal
tract. The mechanisms allowing this adaptability in C. difﬁcile
have been the focus of many recent studies, including those on the
agr quorum-sensing system, alternative sigma factors, two-com-
ponent systems, the global transcription regulator CodY, and the
sigma factor TcdR, which promotes TcdA and TcdB toxin expres-
sion (4–9).
One way by which bacteria sense and respond to changes in
their environment is through signal transduction involving sec-
ondary messenger molecules. The bacterial second messenger
3=-5= cyclic diguanosine monophosphate (c-di-GMP) plays mul-
tiple key roles in bacterial physiology and virulence (10–12). c-di-
GMP has been shown to antagonistically control the motility of
planktonic cells and bioﬁlm formation in several bacterial species.
An increase in the intracellular c-di-GMP concentration typically
induces exopolysaccharide synthesis and adhesion while inhibit-
ing ﬂagellar motility, thereby favoring bioﬁlm formation. A low
concentration of the second messenger has an opposite effect.
c-di-GMP also controls cell differentiation in Caulobacter crescen-
tus (13) and virulence of important human pathogens, including
Vibrio cholerae (14), Borrelia burgdorferi (15), and Pseudomonas
aeruginosa (16). c-di-GMP turnover is controlled by two groups of
enzymes with antagonistic activities. The diguanylate cyclases
(DGCs) contain aGGDEFdomain and synthesize c-di-GMP from
two GTP molecules, whereas the c-di-GMP phosphodiesterases
(PDEs) contain an EAL domain or an HD-GYP domain and hy-
drolyze c-di-GMP into linear pGpG or two GMP molecules, re-
spectively (17–21). Several c-di-GMP effectors are responsible for
the regulatory function of c-di-GMP through transcriptional,
posttranscriptional, translational, and protein-protein interac-
tionmechanisms. Amajor class of c-di-GMPeffector proteins and
the ﬁrst ever described are the PilZ domain c-di-GMP-binding
proteins (22). AlthoughPilZ effectors are numerous, there are also
other c-di-GMP-binding effectors, such as the unrelated tran-
scription factors FleQ in P. aeruginosa andVpsT inV. cholerae (23,
24). In addition to protein effectors, c-di-GMP is also sensed by
RNA effectors, the type I and type II c-di-GMP riboswitches (25,
26). Riboswitches are structured RNA regions typically located in
the 5= untranslated regions of diverse bacterial mRNAs. Ribo-
switches are composed of two modular regions: an aptamer that
recognizes and binds a speciﬁc metabolite and an expression plat-
form that inmost cases controls the expression of the downstream
gene(s) (for recent reviews, see references 27 and 28). Ligand
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binding typically leads to repression of gene expression, most
commonly through transcription termination or inhibition of
translation initiation.
The genome ofC. difﬁcile 630 codes for 18 predictedDGCs and
19 predicted PDEs, many of which have conﬁrmed enzymatic ac-
tivity (29, 30). Sudarsan et al. (26) revealed the presence of a c-di-
GMP-I riboswitch, Cd1, upstreamof the ﬂgB gene, which is part of
one of two loci encoding the ﬂagellum genes in C. difﬁcile. In vitro
studies have shown that binding of c-di-GMP to Cd1 promotes
premature termination of transcription, suggesting that the ex-
pression of ﬂagella in C. difﬁcile would be repressed by c-di-GMP
(26). Purcell et al. (31) demonstrated that overexpression of the
DGCDccA (CD1420) inC. difﬁcile increases the intracellular c-di-
GMP level, which was also associated with a decreased transcrip-
tion of ﬂagellum genes and reduced bacterial motility. In addition
to decreasing motility, DccA overexpression seemed to promote
aggregation of C. difﬁcile cells by an unknown mechanism (31).
The antagonistic regulation by c-di-GMP of motility and sessile
behaviors, namely, aggregation and bioﬁlm formation, was also
recently reported by Souturina et al. (32). The zinc metallopro-
tease Zmp1 encoded by CD2830, which is located downstream of
the c-di-GMP-I riboswitch Cdi1_12, was recently found to cleave
ﬁbronectin, ﬁbrinogen (33), the putative adhesin CD2831, and
the putative surface protein CD3246, the last two encoded by
genes located downstream of the c-di-GMP-II riboswitches
Cdi2_3 and Cdi2_1, respectively (34).
One of the four predicted c-di-GMP-II riboswitches in C. dif-
ﬁcile 630, Cdi2_4, is located less than 200 bp upstream of a pre-
dicted locus for type IV pili (T4P) (25) (Fig. 1A). T4P are surface
appendages involved in many phenotypes in Gram-negative bac-
teria such as P. aeruginosa and Neisseria spp., including but not
limited to adhesion, surface motility (twitching and gliding), bio-
ﬁlm formation and development, cell aggregation, DNA uptake,
and phage absorption (for reviews, see references 35 and 36). T4P
are thin ﬁbers (6 to 9 nm) that can extend several micrometers in
length (37). These ﬁbers are made by the T4P secretion machin-
ery, a type II-related secretion system that promotes pilus elonga-
tion by addition of pilin subunits, and may also retract pili by
depolymerization of pilin subunits, both at the proximal end of
the pilus. T4P gene loci have been predicted formany otherGram-
positive bacteria, including severalClostridium species (38–40).C.
difﬁcile T4P genes are mainly located in one primary cluster of
genes extending fromCD3513 toCD3503 that is predicted to code
for all proteins sufﬁcient for T4P formation (Fig. 1A; see alsoTable
S1 in the supplementalmaterial) (41, 42). Herein, we demonstrate
a role for T4P in cell aggregation ofC. difﬁcile and the regulation of
T4P expression through binding of the second messenger c-di-
GMP to Cdi2_4, a transcriptional riboswitch upstream of the pri-
mary T4P locus.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plas-
mids used in this study are described in Table 1. C. difﬁcile strains were
grown in brain heart infusion (BHI) medium (BD; Bacto) or in BHI
medium supplemented with yeast extract (5 g/liter) and 0.1% L-cysteine-
HCl (BHIS) (43) at 37°C in an atmosphere of 90% N2, 10% CO2, and 5%
H2 in an anaerobic chamber (Coy Laboratory Products). Media for
growth of C. difﬁcile were supplemented with 10 g/ml of thiamphenicol
(BHIS-tm) and 100 g/ml of kanamycin (BHIS-tm-km), 10 g/ml of
norﬂoxacin, and/or 2.5 g/ml of erythromycin, as appropriate. Esche-
richia coli strains were routinely grown at 37°C under aerobic conditions
in Luria-Bertani (LB) medium supplemented with 25 g/ml of chloram-
phenicol or 100 g/ml of ampicillin as needed. For induction of gene
expression in the strains carrying vectors with genes under the control of
the cationic antimicrobial peptide inducible cpr promoter (Pcpr),
BHIS-tm was supplemented with 1g/ml of nisin (2.5%, wt/wt; MP Bio-
medicals).
FIG 1 Schematic representation T4P genes. (A) Genes of the primary T4P locus (CD3513 to CD3503) are downstream of a predicted c-di-GMP-II riboswitch
(Cdi2_4). ORF numbers (bottom) have been abbreviated for clarity and gene annotations (top) are indicated, as proposed by Maldarelli et al. (42) (see Table S1
in the supplemental material). A transcriptional terminator (TT) is predicted 36 bp downstream of pilA1 (see Fig. S6A). (B) The pilA1 and pilB1 mutant strains
were generated using the ClosTron system, and introns were retargeted to insert in the sense orientation in pilA1 between nucleotides 474 and 475 (CD3513-
474/475s intron) or in pilB1 between nucleotides 786 and 787 (CD3512-786/787s intron).
Bordeleau et al.
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Plasmid and strain construction. The pilA1 and pilB1 genes were
insertionally inactivated using a group II intron retargeting approach (44)
adapted for Clostridium, the ClosTron, as previously described (45).
Brieﬂy, the Ll.ltrB intron derivative in plasmid pMTL007C-E5 was retar-
geted to insert after position 474 of CD3513 (pMTL007C-E5-CD3513-
474/475s) or after position 786 of CD3512 (pMTL007C-E5-CD3512-786/
787s) using the Perutka algorithm (46) implemented at http://clostron
.com to predict suitable intron insertion sites and determine the
corresponding intron sequence modiﬁcations required. Both
pMTL007C-E5 derivatives were synthesized by DNA2.0 (Menlo Park,
CA). E. coli CA434 was transformed by electroporation and used as a
donor strain to transfer plasmids by conjugation into a C. difﬁcile 630
erm strain. Transconjugants were plated on BHIS agar plates with thi-
amphenicol to select for the plasmid and norﬂoxacin to select against E.
coli. Integrants could be isolated by subsequently culturing transconju-
gants on BHIS agar plates supplemented with erythromycin. Loss of the
plasmid after overnight growth in BHIS broth was then conﬁrmed by
sensitivity to thiamphenicol. Intron insertion and orientation in pilA1 or
pilB1 was conﬁrmed by PCR screening using primer pairs CD3513-282s-
F/LCF439 or CD3512-795s-F/LCF439 (see Table S2 in the supplemental
material). Insertion of only one intron copy was conﬁrmed by Southern
blotting hybridization (see Fig. S1 in the supplemental material).
The sigD mutant was generated using a group II intron retargeting
approach with a modiﬁed set of template and delivery plasmids (45, 47,
48). The intron was retargeted to insert within sigD (ﬂiA, CD0266) after
position 228, an insertion site previously used to inactivate this gene (5).
The retargeted intron fragment was generated by PCR, amplifying one
portion from pBL64 using primer pair EBSuniv/sigDibs1 and the other
portion from pBL65 using primer pair sigDebs1/sigDebs2. The reaction
products were mixed and used as the template in a PCR with primer pair
sigDibs1/sigDebs1, splicing the two initial PCR products together. The
intron fragment was digested with BsrGI and HindIII and cloned into
pBL100. The resulting plasmid, pBL100::sigD::ermB, was then introduced
into E. coli HB101(pRK24) by electroporation. The pBL100::sigD::ermB
plasmidwas conjugated into theC. difﬁcile 630erm strain, and transcon-
jugants were selected on BHIS-tm-km. Isolates with intron insertions
were selected by screening transconjugants for resistance to erythromycin
and then veriﬁed to have an insertion in sigD by PCR with primer pair
sigDqF/EBSuniv. The mutant was further conﬁrmed to be nonmotile us-
ing a soft-agar assay (31).
For complementation studies, pilA1 and the upstream 497-bp region
encompassing the c-di-GMP-II riboswitchCdi2_4 and putative promoter
region were ampliﬁed by PCR using primer pair RB3513-F2-EcoRI/
CD3513-R3-EcoRI, digested with EcoRI, and ligated into the EcoRI-di-
gested pDccA and pDccAmut plasmids. The resulting pDccA-RB-pilA1
and pDccAmut-RB-pilA1 plasmids were veriﬁed by DNA sequencing. In
both plasmids, the Pcpr promoter and the promoter of pilA1 are divergent
(see Fig. S2 in the supplemental material). Plasmid pDccA-RB-pilA1G9Y,
which codes for the PilA1 pilin mutant with a glycine-to-tyrosine amino
acid substitution at position 9, and plasmids pDccA-RBA70C-pil1A and
pDccA-RBA70G-pilA1, which contain adenine-to-cytosine and adenine-
to-guanine substitutions at position 70 of Cdi2_4, respectively, were gen-
erated by site-directed mutagenesis of pDccA-RB-pilA1 using the
QuikChange Lightning site-directed mutagenesis kit (Agilent Technolo-
gies) and primer pairs listed in Table S2 in the supplemental material.
Mutated plasmids were veriﬁed by DNA sequencing.
For in vitro transcription assays, a synthetic transcription template
containing the Bacillus subtilis glyQS promoter sequence, a GC dinucle-
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Description
Reference or
source
Strain name or genotype
Clostridium difﬁcile
630 Epidemic type X 38
630 erm Erythromycin-sensitive mutant of C. difﬁcile 630 87
pilA1 630 erm CD3513-474s::CT This study
pilB1 630 erm CD3512-786s::CT This study
sigD 630 erm CD0266-228s::TT This study
E. coli CA434 HB101 carrying plasmid R702 88
Plasmids
pCR2.1-TA TA cloning vector Life Technologies
pCR2.1-Rb3513sr pCR2.1-TA with transcription template for Cdi2_4 c-di-GMP-II riboswitch This study
pCR2.1-Rb3513sr-a70c pCR2.1-Rb3513 with A-to-C substitution at nucleotide 70 This study
pCR2.1-Rb3513sr-a70g pCR2.1 with with A-to-G substitution at nucleotide 70 This study
pMTL007C-E5-CD3513-474/475s pMTL007C-E5 with the Ll.ltrB intron retargeted to insert after base 474 in the 630 erm
CD3513 ORF
This study
pMTL007C-E5-CD3512-786/787s pMTL007C-E5 with the Ll.ltrB intron retargeted to insert after base 786 in the 630 erm
CD3512 ORF
This study
pBL64 pCR2.1-intron template part A 48
pBL65 pCR2.1-intron template part B 48
pBL100::sigD::ermB pBL100 with the group II intron-TargeTron (TT) retargeted to insert after base 228 in
the 630 erm CD0266 ORF
This study
pMC-Pcpr cprK promoter cloned into pMC123 E. coli- C. difﬁcile shuttle vector; bla catP 31
pDccA pMC-Pcpr with DccA downstream of Pcpr 31
pDccAmut pMC-Pcpr with DccA(AADEF) downstream of Pcpr 31
pDccA-RB-pilA1 pDccA with CD3513 and 497 bp upstream including the Cdi2_4 riboswitch This study
pDccAmut -RB-pilA1 pDccAmut with CD3513 and 497 bp upstream including the c-di-GMP riboswitch This study
pDccA-RBA70C-pilA1 pDccA-RB-pilA1 with - to-C substitution at nucleotide 70 in Cdi2_4 This study
pDccA-RBA70G-pilA1 pDccA-RB-pilA1 with A-to-G substitution at nucleotide 70 in Cdi2_4 This study
pDccA-RB-pilA1G9Y pDccA-RB-pilA1 with G- to-Y substitution at amino acid 9 in PilA1 This study
Control of Type IV Pilus Biogenesis in C. difﬁcile
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otide transcription start site, and the Cdi2_4 riboswitch sequence, includ-
ing 17 bp upstream of the predicted P1 stem and 93 bp downstream of the
last base of the predicted transcription attenuator stem, was generated in
three steps. First, the 135-bp glyQS promoter sequence, followed by a GC
sequence, was generated by polymerase cycling assembly (PCA) using
oligonucleotides GlyQS-F1 (0.5 M), GlyQS-R1 (40 pM), GlyQS-F2 (40
pM), and GlyQS-R2 (0.5 M) as previously described (49). The 229-bp
extended Cdi2_4 sequence was ampliﬁed by PCR using primers GlyQS-
RB3513-F2 and GlyQS-RB3513-R. The ﬁnal template sequence was then
generated by PCR ampliﬁcation with primers GlyQS-RB3513-F and
GlyQS-RB3513-R using the puriﬁed and 1:1,000-diluted PCA and PCR
products as templates and cloned in pCR2.1-TA (Life Technologies) to
generate plasmid pCR2.1-Rb3513sr. Plasmids pCR2.1-Rb3513sr-a70c
and pCR2.1-Rb3513sr-a70g, which contain, respectively, adenine-to-cy-
tosine and adenine-to-guanine substitutions at position 70 of the c-di-
GMP-II riboswitch, were generated by site-directed mutagenesis of
pCR2.1-Rb3513sr using the QuikChange Lightning site-directed mu-
tagenesis kit and primer pairs listed in Table S2 in the supplemental ma-
terial.
Transmission electron microscopy. Bacteria were inoculated 1:50
from saturated overnight cultures into ﬁlter-sterilized BHIS-tm with 1
g/ml of nisin and grown anaerobically at 37°C for 12 h. Bacteria from 4
ml of culture were centrifuged for 2 min, resuspended in 1 ml of phos-
phate-buffered saline (PBS) and 4% paraformaldehyde, and ﬁxed in the
anaerobic chamber for 45 min. A total of 2.5 l of cell suspension was
adsorbed onto Formar/carbon copper grids (Ted Pella, Inc., Redding CA)
for 2 min, washed twice in ﬁltered deionized water, and stained for 30 s in
two sequential drops of 1% aqueous uranyl acetate. Cells were observed
on a LEO EM 910 transmission electron microscope (Carl Zeiss Micros-
copy, LLC, Thornwood, NY) and recorded with a Gatan Orius SC1000
digital camera with Digital Micrograph 3.11.0 software (Gatan, Inc.,
Pleasanton, CA). All of the cells in 15 (wild type [WT]), 20 (pilA1 and
pilB1) or 50 (sigD) randomly selected grid squares were photographed at
a magniﬁcation of8,000. The images were blinded for quantiﬁcation as
follows: the numbers of cells and pili in each imagewere recorded by three
observers who were unaware of the experimental conditions.
Aggregation assays.Cell aggregation in liquid cultureswasmonitored
as previously reported (31). Brieﬂy, borosilicate tubes containing 10 ml of
BHIS-tm with or without nisin were inoculated with colonies from 24- to
48-h-old BHIS-tm plates and incubated 16 h at 37°C. Aggregation was
assessed bymeasuring the cell density (optical density at 600 nm [OD600])
on the culture tubes before (ODpre) and after (ODpost) vortexing to resus-
pend the cell aggregates. The percentage of cells at the bottom of culture
tubes was inferred using the following formula: [(ODpost  ODpre)/
ODpost] 100. Monitoring of cell aggregation over time was carried out
in fresh BHIS-tm broth with or without nisin inoculated 1/50 with 16-h-
old cultures in BHIS-tm and incubated at 37°C. Cell density (OD600) was
measured on static cultures over a 10-h incubation time, after which the
tubes were vortexed to resuspend the aggregates and measure the cell
density of the total population in each tube.
Molecular biology methods. All the enzymes used in this study were
obtained from New England BioLabs (NEB) and were used according to
the manufacturer’s instructions. Plasmid DNA from E. coli was prepared
with an EZ-10 Spin Column Plasmid DNA Minipreps kit (Bio Basic).
Genomic DNA for PCR veriﬁcation of C. difﬁcile clones was crudely ex-
tracted by boiling cell pellets of overnight cultures in 5% Chelex 100, 200
to 400 mesh (Bio-Rad). Genomic DNA isolation for quantitative PCR
(qPCR) and Southern blot hybridization was performed on 10-ml over-
night cultures using the Marmur’s method with increased lysozyme con-
centration (15 mg/ml) and incubation time (2 h) (50). PCR assays were
performed with the primers described in Table S2 in the supplemental
material in 25-l PCR mixtures with 1 U of Phusion high-ﬁdelity DNA
polymerase. PCR conditions were as follows: (i) 30 s at 98°C, (ii) 30 cycles
of 10 s at 98°C, 20 s at a suitable annealing temperature, and 15 to 300 s at
72°C, and (iii) 5 min at 72°C. When needed, PCR products were puriﬁed
using an EZ-10 Spin Column PCR product puriﬁcation kit. E. coli was
transformed by electroporation according to the method of Dower and
colleagues (51). Transformation was carried out in 0.1-cm electropora-
tion cuvettes using a Bio-RadGenePulser Xcell apparatus set at 25F, 200
, and 1.8 kV.
RNA isolation and qRT-PCR. RNA was isolated from C. difﬁcile cul-
tures grown in BHIS-tm to an OD600 of 0.7 without or with 0.1 and 1
g/ml of nisin. Samples were mixed with an equal volume of cold 1:1
ethanol-acetone and stored at80°C. Total RNA extraction was achieved
using an RNeasy minikit (Qiagen) according to the manufacturer’s in-
structions and glass bead lysis. Cells resuspended in 1 ml of RLT buffer
(Qiagen) were submitted to 2 cycles of 40 s at 4 m/s on a Fastprep 24
apparatus (MP Bimedicals) with 0.5 g of 0.1-mm glass beads. Puriﬁed
RNA samples were then subjected to gDNA digestion using Turbo DNase
(Ambion) by following the manufacturer’s instructions. Quantitative re-
verse transcription-PCR (qRT-PCR) assays were performed on the
RNomics platform of the Laboratoire de Génomique Fonctionnelle de
l’Université de Sherbrooke (http://lgfus.ca). RNA integrity was assessed
using an Agilent 2100 Bioanalyzer (Agilent Technologies). Reverse tran-
scription was performed on 2.2g of total RNA with Transcriptor reverse
transcriptase, randomhexamers, deoxynucleoside triphosphates (dNTPs;
Roche Diagnostics), and 10 U of RNAseOUT (Invitrogen Life Technolo-
gies) according to the manufacturer’s protocol in a total volume of 20 l.
All forward and reverse primers were individually resuspended to 20 to
100 M stock solutions in Tris-EDTA buffer (IDT) and diluted as a
primer pair to 1 M in RNase DNase-free water (IDT). qPCRs were per-
formed in 10-l volumes in 96-well plates on a CFX-96 thermocycler
(Bio-Rad) with 5 l of 2 iTaq universal SYBR green supermix (Bio-
Rad), 10 ng (3l) of cDNA, and 200nM(ﬁnal concentration; 2l) primer
pair solutions. The following cycling conditions were used: 3 min at 95°C
and 50 cycles of 15 s at 95°C, 30 s at 60°C, and 30 s at 72°C. Relative
expression levels were calculated using a model taking into account mul-
tiple stably expressed reference genes (52) and housekeeping genes adk,
rpoA, and gyrA evaluated by geNorm (53). Primer design (see Table S2 in
the supplemental material) and validation were evaluated as described
elsewhere (54). In every qPCR run, a no-template control was performed
for each primer pair and a no-reverse transcriptase control was performed
for each cDNA preparation. Experiments were carried out three times on
three biological replicates, and results were combined.
Plasmid copy number quantiﬁcation. Genomic DNA was isolated
from C. difﬁcile cultures grown in BHIS to mid-exponential phase (OD600
of 0.6) or stationary phase (16 h). Gene copy number was measured by
qPCR using 10 ng (3l) of genomic DNA (gDNA) as described herein for
cDNA quantiﬁcation (see qRT-PCR) using primers listed in Table S2 in
the supplemental material. CD3513 (pilA1) was targeted to measure its
relative gene copy number in the WT strain harboring plasmids pDccA-
RB-pilA1 or devoid of vector. The data were analyzed using the threshold
cycle (CT) method using CD3512 (pilB1) as the chromosomal copy
number reference. Experiments were carried out three times on two bio-
logical replicates, and results were combined.
Single-round in vitro transcription assays. Transcription reactions
were conducted as previously described (55), with minor modiﬁcations.
Brieﬂy, DNA templates for in vitro transcription maintained in plasmids
pCR-2.1-Rb3513sr, pCR-2.1-Rb3513sr-a70c, and pCR-2.1-Rb3513sr-
a70g were ampliﬁed by PCR using primers GlyQS-RB3513-F and GlyQS-
RB3513-R. The dinucleotide GpC, fused with the 17 nucleotides (nt) up-
stream of the predicted P1 stem, was used to initiate transcription.
Transcription reactions were expected to stop at the predicted transcrip-
tion terminator for terminated RNA species (approximately 146 nt) or to
stop at the end of the template for read-through species (231 nt). Reaction
mixtures containing 300 fmol of DNA template in a buffer containing 150
M GpC, 2.5M ATP and CTP, 0.75M UTP, 2Ci of [-32P]UTP, 50
mM Tris-HCl (pH 8.0 at 23°C), 20 mM MgCl2, 0.1 mM EDTA, 1 mM
dithiothreitol (DTT), 10% glycerol, and c-di-GMP or c-di-AMP (Biolog
Life Science Institute, Bremen), when needed, were incubated 5 min at
Bordeleau et al.
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37°C. Transcription was initiated by addition of 0.25 U of E. coli RNA
polymerase holoenzyme (Epicentre) and incubation for 15 min at 37°C.
Reactions were completed by the addition of each NTP to a ﬁnal concen-
tration of 2.5 M and 0.45 mg/ml of heparin to avoid transcription rein-
itiation. After an additional 15-min incubation period at 37°C, reactions
were stopped by addition of an equal volumeof 95% formamide. Reaction
products were separated on 8% denaturing polyacrylamide gels. Exposed
phosphor imager screens were scanned and analyzed using an FX molec-
ular imager and Quantity One software (Bio-Rad). The c-di-GMP con-
centration needed to obtain half of the change, T50, was determined as
described previously (55). Brieﬂy, the T50 was analyzed by nonlinear re-
gression curve ﬁtting using GraphPad Prism and the equation  RTi	
RTmax ([c-di-GMP]/(T50 	 [c-di-GMP]) where  is the percentage of
read-through and RTi and RTmax are the initial and maximal changes,
respectively, in transcription termination.
RNAmolecularmarkers. In order to verify the length of transcription
reaction products, two RNA molecular markers corresponding to the
length of the predicted terminated (146 nt) and read-through (231 nt)
RNA species were generated using T7 RNA polymerase (Life Technolo-
gies). Templates for T7 RNA transcription were prepared by PCR ampli-
ﬁcation on C. difﬁcile 630 genomic DNA using primer pairs T7RB3513-
F/GlyQS-RB3513term-R2 and T7RB3513-F/GlyQS-RB3513-R and then
puriﬁed by denaturing PAGE and electroelution. Both transcripts start
with a 5= GCG sequence to minimize 5=-end heterogeneity of the RNA
population (56). RNA labeled at the 5= end with 32P was obtained by
dephosphorylation with shrimp alkaline phosphatase (Affymetrix) and
phosphorylation with T4 polynucleotide kinase (NEB) and [
-32P]ATP
according to the manufacturer’s instructions. Reactions products were
separated by denaturing PAGE, electroeluted, ethanol precipitated, and
dissolved in water.
RESULTS
T4P biogenesis is induced by c-di-GMP. Since the putative T4P
primary locus in C. difﬁcile (open reading frames [ORFs] CD3513
to CD3503) is located downstream of a predicted c-di-GMP-II
riboswitch (Fig. 1A), we speculated that T4P are involved in the
previously reported aggregation ofC. difﬁcile cells in liquid culture
upon elevation of intracellular c-di-GMP levels (31). CD3513 is
the ﬁrst gene of the T4P primary locus and likely codes for a major
pilin subunit (41, 42). Therefore, it is named pilA1 as proposed by
Maldarelli et al. (42). The second gene of the T4P primary
locus, CD3512, encodes a homolog of PilB, a predicted hexa-
meric ATPase thought to supply the energy required for pilus
assembly through the successive addition of pilin subunits.
PilB is essential for T4P secretion in P. aeruginosa and Neisseria
gonorrhoeae (named PilF in N. gonorrhoeae) (57, 58). CD3512 and
the downstream genes are part of the primary T4P locus and
named as proposed byMaldarelli et al. (42); i.e., CD3512 is named
pilB1, whereas the second pilB gene, CD3296, contained in the
secondary T4P gene operon (CD3296 to CD3291), is named pilB2
(Fig. 1A).
Reasoning that the gene located immediately downstream of
the c-di-GMP-II riboswitchCdi2_4 ismost likely the gene directly
regulated by c-di-GMP, at the transcriptional or translational
level, we disrupted the putative pilin gene pilA1 using the group II
intron retargeting approach adapted to clostridia (ClosTron) (Fig.
1B; see also Fig. S2 in the supplemental material). We also dis-
rupted pilB1 to verify the role of T4P independently of the PilA1
pilin if pilA1 was not involved in T4P biogenesis (Fig. 1B; see also
Fig. S2). The pilB1 gene could also be regulated by c-di-GMP, as it
is located directly downstream of pilA1. Although the secondary
pilB2 gene could have a redundant function, we hypothesized that
pilB1 was essential for pilus biogenesis in C. difﬁcile. The intracel-
lular c-di-GMP level in the C. difﬁcile 630erm strain (WT), or its
pilA1 and pilB1 mutants, was manipulated by introducing pDccA
to express the C. difﬁcile DGC DccA under a nisin-inducible pro-
moter as described before (31). The empty vector (pMC-Pcpr)
was used as a negative control (Table 1).
Examination of the cells by transmission electron microscopy
revealed that upon expression of DccA in the WT strain, c-di-
GMP induces the formation of pilus-like structures while inhibit-
ing biosynthesis of ﬂagella (Fig. 2A). In contrast, the WT strain
with the empty vector displayed many ﬂagella but no pili at its
surface under the same inducing conditions. Interestingly, the av-
erage number of pili/cell was only 2.4, as many cells did not
display any pili (Fig. 2B; see also Fig. S3A in the supplemental
material). To verify that the appendages observed on the WT
strains expressingDccAwere not ﬂagella, we also used a sigD (ﬂiA,
28) disruption mutant of the C. difﬁcile 630 erm strain, which
exhibits impaired motility (Fig. 2A) (59). The average number of
pili/cell for the sigD strain expressing DccA was comparable to
that for theWT strain expressingDccA (Fig. 2B; see also Fig. S3A).
No ﬂagellum or pilus could be detected on the surface of the sigD
mutant strain carrying the empty vector. Disruption of either
pilA1 or pilB1 virtually abolished the formation of pilus-like struc-
tures at the surface of the cells despite DccA expression sufﬁcient
to almost completely abolish ﬂagellum formation. Moreover, ma-
ture PilA1 pilin could be detected in extracellular fractions upon
DccA expression in the WT strain but not in the pilA1 or pilB1
mutant (see Fig. S3B). Collectively, these results support the no-
tion that the observed appendages induced by c-di-GMP are T4P,
as they require predicted T4P genes pilA1 and pilB1 (and/or the
downstream T4P genes) for their biogenesis.
T4P are involved in c-di-GMP-dependent aggregation. To
investigate further the roles of pilA1 and pilB1 and of pilus-like
structures, we monitored cell aggregation in cultures of the C.
difﬁcile 630 erm strain (WT) and the pilA1 and pilB1 mutants
bearing pDccA or pDccAmut (Table 1), which expresses a catalyt-
ically inactive mutant of DccA unable to produce c-di-GMP. Ex-
tensive cell aggregation occurred for the WT strain with pDccA
upon nisin induction, with approximately 90% of the cells pellet-
ing to the bottom of the culture tube after a 16-h incubation pe-
riod (Fig. 3A; see also Fig. S4A in the supplemental material).
Under the same conditions, less than 2.5% cell aggregation was
observed for the WT strain with pDccAmut, and less than 0.05%
cell aggregation was observed for the uninduced WT strain with
pDccA (Fig. 3A; see also Fig. S4A). Like the WT strain, neither the
pilA1 nor the pilB1 mutant strain signiﬁcantly aggregated upon
expression of dccAmut or without induction. Interestingly, both
mutant strains with pDccA exhibited a 2-fold reduction (pilA1,
P  0.005; pilB1, P  0.0028) compared to the WT strain with
pDccA, displaying 40 to 45% cell aggregation upon nisin induc-
tion. These observations suggest that pilA1 and pilB1 contribute
signiﬁcantly to c-di-GMP-regulated cell aggregation, but an addi-
tional c-di-GMP-regulated factor(s) is likely involved.
We noticed that the absorbances of cultures of aggregated cells
after resuspension were slightly lower than those of uninduced
control cultures (see Fig. S4A in the supplemental material), sug-
gesting that the aggregates could have resulted from the accumu-
lation of dead cells. We veriﬁed that the aggregated cells were
viable and, most importantly, that observation of the optical den-
sity reﬂected the viable cell counts by comparing the CFU/ml in
samples collected before and after suspension of the induced and
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uninduced cells carrying pDccA (see Fig. S4C). As expected, cul-
ture samples collected before and after resuspension of the aggre-
gates exhibited concentrations of viable cells in agreement with
the observed culture absorbance measurements (see Fig. S4A
and C). This observation also conﬁrmed that the observed c-di-
GMP-dependent aggregation phenotype does not result from
cell death and subsequent pelleting of cell debris over time.
PilA1 pilin complementation restores c-di-GMP-induced
aggregation. The lack of cell aggregation in the pilA1 mutant (as
well as in the pilB1 mutant used in this study as a presumed T4P-
negative control) could solely result from polar effects on the ex-
FIG 2 c-di-GMP induces T4P formation. (A) Transmission electron micros-
copy of the C. difﬁcile 630erm strain (WT) or its sigD mutant with pDccA or
the empty vector and the pilB1 and pilA1mutants with pDccA from 12-h static
liquid cultures in BHIS-tm with nisin (1 g/ml). Scale bars  1 m. Open
arrowheads show ﬂagella and closed arrowheads show pili. (B) Mean number
of pili for each cell in 15 (WT), 20 (pilA1 and pilB1), or 50 (sigD) randomly
selected grid squares photographed at a magniﬁcation of8,000. The images
were blinded for quantiﬁcation as described in the text. Data were analyzed by
one-way analysis of variance (ANOVA) and Dunnett’s multiple-comparison
test comparing values to those for theWT strainwith the empty vector (ns,P
0.05; ***, P 0.001; *, P 0.05).
FIG 3 T4P are required for c-di-GMP-dependent aggregation of C. difﬁcile
planktonic cells. Cell aggregationwasmonitored bymeasuring the absorbance
(OD600) of supernatants before (ODpre) and after (ODpost) vortexing (see Fig.
S4A in the supplemental material) for 16-h static liquid cultures in BHIS-tm.
Aggregation was expressed as a percentage of cells at the bottom of culture
tubes, determined with the equation [(ODpost  ODpre)/ODpost]  100. (A)
Cell aggregation of the C. difﬁcile 630 erm strain (WT) or its pilB1 and pilA1
insertion mutants upon expression of the diguanalyte cyclase DccA (pDccA)
or inactive DccA mutant (pDccAmut) by induction with 0 or 1 g/ml of nisin.
(B) Cell aggregation complementation assays using the pilA1 gene and its
upstream Cdi2_4 riboswitch cloned into a plasmid expressing DccA (pDccA-
RB-pilA1) or expressingDccAmut (pDccAmut-RB-pilA1). Complementation of
the pilA1 mutant was also carried out using plasmids expressing PilA1G9Y
(pDccA-RB-pilA1G9Y) or containing the nucleotide substitution A70C or
A70G in the Cdi2_4 riboswitch (pDccA-RBA70C-pilA1 and pDccA-RBA70G-
pilA1). The result for the WT strain with pDccA from panel A was duplicated
to ease interpretation. Themeans and standard deviations obtained from three
independent assays are shown. One-way ANOVA with Dunnett’s multiple-
comparison posttest was used to compare the strains to the WT strain with
pDccA (ns, P 0.05; **, P 0.01).
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pression of the downstream genes. To rule out this possibility, the
wild-type pilA1 gene and its upstream regulatory region in-
cluding the c-di-GMP-II riboswitch Cdi2_4 (RB) were intro-
duced into pDccA and pDccAmut to generate pDccA-RB-pilA1
and pDccAmut-RB-pilA1 for complementation experiments
(see Fig. S2 in the supplemental material). Complementation
of the pilA1 mutant using pDccA-RB-pilA1 increased cell ag-
gregation 2-fold (Fig. 3B), from  40 to 80% compared to the
value for the same pilA1 mutant bearing pDccA (Fig. 3A). Ag-
gregation of the pilA1 mutant complemented with pDccA-RB-
pilA1 was indistinguishable from that of the WT strain bearing
pDccA (P  0.88). Complemented cells also displayed pili at
their surface (see Fig. S3A, C, and D).
Complementation of the pilA1 mutant using a plasmid ex-
pressing a PilA1G9Y prepilin leader peptide substitution mutant,
pDccA-RB-pilA1G9Y, did not restore cell aggregation toWT levels.
G9 of PilA1 corresponds to a highly conserved glycine residue
located at the 1 position of the predicted cleavage site in the
prepilin subunit. This residue was shown to be necessary for the
cleavage and subsequent assembly of pilin subunits into pili in P.
aeruginosa (60). Consistent with this, PilA1G9Y could be detected
only in whole-cell lysates and not in the extracellular fraction
when the pilA1 mutant was complemented with pDccA-RB-
pilA1G9Y, thereby conﬁrming that the G9Y mutation prevents the
export of PilA1 and the formation of pili inC. difﬁcile (see Fig. S3B
in the supplemental material). The pilA mutant complemented
with pilA1G9Y did not display visible pili (see Fig. S3A, C, and D).
As expected, none of the strains containing pDccAmut-RB-
pilA1 (i.e., complemented for pilA1 but expressing DccAmut) were
able to aggregate (Fig. 3B). Finally, the additional copies of the
pilA1 gene in the pilB1 mutant with pDccA-RB-pilA1 did not re-
store cell aggregation to WT levels (Fig. 3B). Altogether, these
observations support that the PilA1 pilin itself is involved in c-di-
GMP-regulated cell aggregation.
Cell aggregation occurs during exponential growth. c-di-
GMP-regulated aggregation was also monitored more closely for
all strains by measuring the absorbance of cultures over a 10-h
incubation time. Upon nisin induction, cell aggregates of the WT
strain with pDccA could be visually observed in suspension after
5 to 6 h as the cells in suspension reached an OD600 of0.8 to
0.9 (Fig. 4A). From this breakpoint, longer incubation time re-
sulted in decreased absorbance of the supernatant down to an
OD600 of0.3 after 10 h and in cells accumulating at the bottom
of the tube after only 6 h (Fig. 4A and C). Interestingly, cell aggre-
gation was clearly impaired for both the pilA1 and pilB1 mutants
compared to the WT strain; in the presence of nisin, the absor-
bance of the culture in suspension continued to increase after 6 h
to reach an OD600 of 1.2 to 1.4 after 10 h, although a much
reduced cell pellet could also be observed (Fig. 4A and C). In
contrast, no cell aggregation could be observed and the absor-
bance of the cultures increased steadily to reach stationary phase at
an OD600 of2.0 after 10 h for all strains cultured without induc-
tion (see Fig. S5A and B in the supplemental material) or strains
containing DccAmut induced with nisin (see Fig. S5C).
Interestingly, observation of aggregation over shorter incuba-
tion times revealed that while complementation of the pilA1 mu-
tant using pDccA-RB-pilA1 seemed to restore the cell aggregation
phenotype in overnight cultures (Fig. 3B), it promoted an earlier
and more drastic cell aggregation phenotype (Fig. 4). In fact, the
absorbance of cells in suspension of both the WT and the pilA1
mutant strains bearing pDccA-RB-pilA1 barely increased past the
4-h incubation time, stabilizing to an OD600 of 0.3. Cell aggre-
gates in suspension were already apparent and a pellet became
increasingly visible at the bottom of the culture tubes (Fig. 4B and
C). Increased cell aggregation is likely caused by the increased
pilA1 copy number provided by pDccA-RB-pilA1. Indeed, real-
time qPCR experiments conﬁrmed that pDccA-RB-pilA1 main-
tains at about 34.2  2.0 and 17.3  0.2 copies per cell in the
exponential and stationary phases, respectively. Again, comple-
mentation of the pilA1 mutant by expressing the pilA1G9Y mutant
from pDccAmut-RB-pilA1G9Y (Fig. 4B) did not restore cell aggre-
gation to WT levels and was indistinguishable from the pilA1 mu-
tant strain containing pDccA (Fig. 4A), thereby conﬁrming that
the mature PilA1 pilin is involved in cell aggregation.
c-di-GMP induces the expression of the primary T4P gene
cluster. Typically, riboswitches control either mRNA transcrip-
tion termination through the formation of a Rho-independent
terminator stem-loop or translation initiation through the se-
questration of the Shine-Dalgarno sequence or start codon. Al-
though PilA1 protein levels were elevated upon increased c-di-
GMP levels (see Fig. S3B in the supplemental material), we
sought to verify whether it resulted from transcriptional regu-
lation. To assess the effect of increased intracellular c-di-GMP
levels on the transcription of the genes downstream of the ri-
boswitch, we carried out real-time quantitative reverse tran-
scription-PCR (qRT-PCR) experiments on cDNAs obtained
from total RNAs isolated from the C. difﬁcile 630 erm strain
with either pDccA or pDccAmut. The relative expression of the
gene directly downstream of the riboswitch Cd2_4, pilA1, in-
creased nearly 40-fold upon high intracellular c-di-GMP levels
(Fig. 5A). Likewise, the expression of all genes downstream of
pilA1, with the exception of pilD2, was signiﬁcantly higher (2- to
10-fold increase) under induced conditions. Expression of the
three additional predicted pilin genes pilJ (CD0755), pilW
(CD2305), and pilA2 (CD3294), located in three distinct chromo-
somal loci remote from the primary T4P gene cluster, was not
signiﬁcantly modulated by c-di-GMP, as their corresponding
transcript levels remained virtually unchanged by increased intra-
cellular levels of c-di-GMP (Fig. 5B). The lower increase in tran-
script levels for genes downstreamof pilA1 could result from tran-
scription attenuation caused by the presence of a predicted Rho-
independent terminator (WebGeSTer DB prediction [61])
located 36 bp downstream of pilA1 stop codon (Fig. 1A; see also
Fig. S6A in the supplementalmaterial). Indeed, pilA1 and pilB1 are
cotranscribed, as detected by qRT-PCR (see Fig. S7). Further-
more, pilA1 disruption abolishes the increase of expression of the
downstream genes pilB1 and pilC1 observed in the WT strain
upon high c-di-GMP levels (Fig. 5C). However, c-di-GMP-inde-
pendent transcription of pilB1 and downstream genes is also ini-
tiated from at least one additional promoter located directly up-
stream pilB1 (see Fig. S6B and C).
TheT4Pprimary locus is locateddownstreamof a functional
transcriptional c-di-GMP-II riboswitch. Our analysis of T4P
gene expression suggested that Cdi2_4 is a positive transcrip-
tional riboswitch. Although the predicted secondary structure
of the Cdi2_4 riboswitch contains features of a functional c-di-
GMP-II aptamer (i.e., P1, P2, P3, and P4/pseudoknot struc-
tures), it was not initially predicted to have a transcriptional
terminator as an expression platform (25). However, we were
able to predict a possible terminator structure in the vicinity of
Control of Type IV Pilus Biogenesis in C. difﬁcile
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Cdi2_4 using the RNAfold webserver (62). We inferred that
formation of the P1 stem upon c-di-GMP binding to the ap-
tamer could act as an antiterminator stem that sequesters the
proximal half of a putative Rho-independent terminator stem
(Fig. 6A).
To test this hypothesis, a single-round in vitro transcription
assay was developed to differentiate premature transcription
termination from full-length transcription upon c-di-GMP
binding. Using this assay, we ﬁrst demonstrated that c-di-GMP
increased transcription past the predicted terminator (Fig. 6B).
Indeed, the percentage of read-through transcripts increased
with the c-di-GMP concentration (Fig. 6C). Moreover, the
amount of c-di-GMP that achieved half of the transcription
elongation change, deﬁned as the T50 (63), was determined to
be 70  12 nM, which is a physiologically relevant concentra-
tion in C. difﬁcile (31). These results support the notion that
binding of c-di-GMP to the Cdi2_4 riboswitch promotes tran-
scription elongation.
The Cdi2_4 aptamer speciﬁcally binds c-di-GMP. Smith and
colleagues (64) determined the structure and binding pocket
nucleotides of a c-di-GMP-II aptamer from Clostridium aceto-
butylicum, Cac-1-2. Modeling of the Cdi2_4 aptamer tertiary
structure revealed the conservation of nucleotides involved in
ligand recognition through noncanonical base-pairing (A69
and G73) with c-di-GMP guanines and base stacking interac-
tions (A13, A61, and A70) (Fig. 7A) (64). This led us to test
FIG 4 Time course monitoring of cell aggregation reveals differences in aggregation rate. Cell aggregation from static liquid cultures was monitored by
measuring the optical densities (600 nm) at 30-min intervals. (A) Cell aggregation of theC. difﬁcile 630erm strain (WT) or its pilB1 and pilA1 insertionmutants
upon expression of the diguanalyte cyclase DccA (pDccA) or inactive DccA mutant (pDccAmut). (B) Cell aggregation complementation assays using plasmids
pDccA-RB-pilA1, pDccA-RB-pilA1G9Y, or pDccA-RBA70C-pilA1 and pDccA-RBA70G-pilA1. (C) Representative images of the aggregation phenotypes observed in
liquid cultures for selected genotypes. The expression of dccA or dccAmut was induced with 1 g/ml of nisin. The means and standard deviations obtained from
three independent assays are shown. Differences in the duration of the lag phase, independent of the strains, were attenuated by adjusting the time point of the
beginning of the exponential phase as in the uninduced control cultures (see Fig. S5 in the supplemental material).
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whether increased read-through transcription in the presence
of c-di-GMP was triggered by its binding to the riboswitch
aptamer or by unforeseen interaction of c-di-GMP in single-
round transcription assays. Reasoning that mutations in the
aptamer that decrease c-di-GMP binding should in return af-
fect the ability of the whole riboswitch to regulate read-through
transcription, we generated two single-nucleotide substitu-
tions in Cdi2_4, A70G and A70C, that were shown to reduce
the binding afﬁnity of Cac-1-2 25,000- and 2-fold, respectively
(64). Similarly, the A70G substitution in Cdi2_4 abolished the
effect of c-di-GMP on promoting transcription elongation,
while the A70C substitution did not impact considerably the
percentage of read-through transcripts (Fig. 7B). To further
test the speciﬁcity of Cdi2-4 for c-di-GMP, we carried out the
same assay using c-di-AMP, a close c-di-GMP analog, and ob-
served that c-di-AMP does not increase the percentage of read-
through transcripts. Together, these results support the notion
that increased transcription elongation is promoted by speciﬁc
interactions between c-di-GMP and nucleotides of the Cdi2_4
aptamer binding pocket and support a model in which c-di-
GMP promotes T4P genes transcription through binding to the
upstream c-di-GMP-II riboswitch.
To assess the importance of the c-di-GMP riboswitch for
regulating the expression of pilA1, complementation of the
pilA1 mutant by adding plasmids pDccA-RBA70C-pilA1 and
pDccA-RBA70G-pilA1 was attempted. As expected, the A70C
substitution did not impair Cdi2_4 riboswitch activity, as the
pilA1 mutant with pDccA-RBA70C-pilA1 displayed very similar
cell aggregation phenotypes in both overnight cultures and
shorter incubation times than the pilA1 mutant with pDccA-
RB-pilA1 (Fig. 3A and B). Surprisingly, the A70G substitution
did not completely prevent complementation of the pilA1 mu-
tant by plasmid-borne copies of pilA1 in aggregation assays.
Indeed, cell aggregation of the pilA1 mutant containing
pDccA-RBA70G-pilA1 after 16 h of incubation was about 80%, i.e.,
not signiﬁcantly lower than that of the WT strain with pDccA or
the pilA1 mutant with pDccA-RB-pilA1 (Fig. 3B). Closer exami-
nation over shorter incubation times also revealed increased cell
aggregation of the pilA1 mutant with pDccA-RBA70G-pilA1 com-
pared to the noncomplemented strain (pilA1 pDccA), as the op-
tical density of the cells in suspension remained at about 0.5 for the
pilA1 mutant with pDccA-RBA70G-pilA1, compared to about 1.3
for pilA1 with pilA1 pDccA (Fig. 4B). Nevertheless, the A70G sub-
stitution seemed to impair the function of the c-di-GMP ribo-
switch, as cell aggregation of the pilA1 mutant with pDccA-
RBA70G-pilA1 was lower than for the same pilA1 mutant
complemented with pDccA-RB-pilA1. After 5 to 6 h of incuba-
tion, the absorbance of the cells in suspension of the pilA1 mutant
complemented with pDccA-RB-pilA1, or the control riboswitch
substitution mutant plasmid pDccA-RBA70C-pilA1, did not con-
FIG 5 c-di-GMP increases the expression of the T4P primary cluster genes. Shown are relative transcript levels of T4P primary cluster genes (A) and alternative
T4P pilin genes (B) in the WT strain and T4P primary cluster genes in the pilA1 mutant strain background (C). Bars represent the transcript levels (fold) relative
to the C. difﬁcile 630erm strain containing the pDccAmut control plasmid induced with 1g/ml of nisin as determined by qRT-PCR using adk, gyrA, and rpoA
as internal references for normalization. The means and standard deviations obtained from three independent assays are shown. One-way ANOVA with
Dunnett’s multiple-comparison posttest was used to compare the values to that of the strain with the pDccAmut control plasmid induced with 1 g/ml of nisin
(****, P 0.0001; ***, P 0.001; **, P 0.01; *, P 0.05).
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tinue to increase past about 0.3 while the pilA1 mutant with pD-
ccA-RBA70G-pilA1 reached and remained at an OD600 of 0.5 as
the cell aggregates accumulated at the bottoms of the tubes (Fig.
4B and C).
DISCUSSION
Insightful studies have revealed the versatility of functions con-
ferred by T4P as well as the complexity of their assembly and
regulation in Gram-negative bacteria. Recently, T4P were pre-
dicted to be also encoded by many Gram-positive bacteria (38–
40). Yet, the role of T4P in Gram-positive bacteria has only been
determined for the cellulolytic bacterium Ruminococcus albus, for
which T4P are important for adhesion to cellulose (65), and Clos-
tridium perfringens, for which T4P pilins appear at the bacterial
surface and T4P are involved in gliding motility and bioﬁlm for-
mation (39, 66).
In this work, we have unraveled the contribution of T4P in the
aggregation of C. difﬁcile and the regulation of their synthesis by a
c-di-GMP-dependent transcriptional riboswitch activator. Al-
though our study represents the ﬁrst genetic and functional char-
FIG 6 Cdi2_4 is a transcriptional c-di-GMP-II riboswitch. (A) Predicted
Cdi2_4 c-di-GMP-II riboswitch-mediated transcription regulation. c-di-
GMP is predicted to increase transcription past a predicted Rho-independent
transcription terminator.Upon c-di-GMPbinding to the aptamer, the P1 stem
folds and sequesters nucleotides needed for the terminator formation and
therefore acts as an antiterminator. Positions 231 and 146 correspond to the
last nucleotides of the full-length transcript and the predicted terminated tran-
script, respectively. GC nucleotides (underlined) were added to the template
for transcription priming using GC dinucleotides. The predicted Cdi2_4 ap-
tamer is illustrated based on its predicted secondary structure (25). The tran-
scription terminator folding was predicted using the RNAfold web server
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) (62). (B) Single-round in
vitro transcription of the Cdi2_4 riboswitch template. Transcription reactions
were carried out as a function of c-di-GMP concentration. Read-through (RT)
and terminated (T) products are indicated on the right. Transcripts of 231 nt
(RT) and 146 nt (T) were labeled and used as molecular size makers (MWM).
The reactions were done in duplicate, and a representative image is shown. (C)
The percentages of read-through products are plotted as a function of c-di-
GMP concentration as quantiﬁed from panel B. The plot shows a two-state
model from which a T50 value of 70 12 nM c-di-GMP was calculated.
FIG 7 Cdi2_4 riboswitch transcription regulation requires speciﬁc c-di-GMP
binding. (A) Predicted secondary structure and tertiary interactions of the
Cdi2_4 aptamer upstream of pilA1. The cdi2_4 aptamer structure is based on
the three-dimensional structure of the Cac-1-2 c-di-GMP-II aptamer from
Clostridium acetobutylicum (64). For clarity, P1 (blue), P2 (gray), P3 (purple),
and P4/pseudoknot (green) are shown in color. The c-di-GMP molecule is
shown in red. Positions 69, 70, and 73 correspond to nucleotides interacting
with c-di-GMP in Cac-1-2. Bases pairs are indicated with standard symbols
(89). (B) Single-round in vitro transcription of the Cdi2-4 riboswitch. Tran-
scription reactions were performed on DNA templates carrying no mutation
(WT) or a single-nucleotide substitution (A70C andA70G)without or with 10
Mc-di-GMPor c-di-AMP. Read-through (RT) and terminated (T) products
are indicated on the right. The percentages of read-through (RT %) products
are indicated under every lane.
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acterization of T4P in C. difﬁcile, these structures were most likely
observed much earlier. Borriello et al. (67) reported ﬁlaments
measuring 4 to 9 nm in diameter and up to 6 m long located at
the poles of agar-grown cells, mostly gathered in bundles, al-
though only 0 to 6% of the cells presented pilus-like structures
depending on the strains. This is similar to the size of the T4P on
the liquid-grown planktonic cells reported herein, which we only
observed as single ﬁlaments. Andwhilemost cells displayedT4P at
their surface, we also observed a noticeable population of cells
devoid of T4P with high c-di-GMP levels. Although this observa-
tion could simply result frompilus breakages during sample prep-
aration, we cannot rule out that T4P synthesis is subject to addi-
tional stochastic regulation mechanisms.
Recently Piepenbrink et al. (68) reported the display of T4P at
the surface ofC. difﬁcileR20291 after anaerobic growth at 37°C on
Columbia agar plates and prolonged incubation at room temper-
ature. Composition analysis of these appendages by double im-
munogold staining revealed the presence of both PilA1 and PilJ in
C. difﬁcile R20291 pili (68). Despite that PilA1 is hypothesized to
be the major pilin, the individual role of PilJ and PilA1 in the
biogenesis of T4P in C. difﬁcile 630 remains unknown. Yet, we
clearly show that disruption of pilA1 (or pilB1) abolished pilus
formation and signiﬁcantly reduced cell aggregation. Incidentally,
the low residual pilus formation observed in the pilB1 mutant
background could result from a partial complementation by the
second PilB protein, encoded by the pilB2 gene. Ectopic expres-
sion of pilA1 complemented the pilA1 mutant of C. difﬁcile 630 in
cell aggregation experiments, conﬁrming that PilA1 is a key factor
for both T4P biogenesis and aggregation. We speculate that if PilJ
or another pilin is the main component of C. difﬁcile T4P, PilA1
might play a key regulatory role in the assembly of the pilus struc-
ture, as demonstrated for some minor pilins in other species
(69–71). Therefore, the PilA1 pilin may indirectly contribute to
T4P-mediated aggregation. Additional studies are required to un-
derstand the relative contribution of PilJ and PilA1 to T4P forma-
tion in C. difﬁcile as well as the possible contribution of the three
other predicted pilins encoded by the primary T4P locus, PilK,
PilU, and PilV, and the two predicted pilins PilW and PilA2.
T4P were previously shown to be regulated by c-di-GMP in
other bacteria. Most interestingly, the c-di-GMP-binding PilZ
domain retains its name from the PilZ protein from P. aerugi-
nosa, which is required for twitching motility and T4P biogen-
esis in this species (22, 72). Ironically, PilZ is the only one of the
eight proteins containing a PilZ domain in P. aeruginosa that
was unable to bind c-di-GMP in in vitro assays (73). However,
the c-di-GMP-binding protein FimX is required for T4P bio-
genesis and twitching motility in P. aeruginosa (74–76). In Xan-
thomonas axonopodis pv. citri, the orthologous PilZ protein was
shown to bind to both FimX and the ATPase PilB required for
pilin polymerization (77). In these species, current evidence
suggests that c-di-GMP regulates T4P biogenesis and function
by mechanisms relying on protein-protein interactions. Ribo-
switch-mediated transcription regulation reported herein is a
novel mechanism of T4P biogenesis regulation by c-di-GMP
signaling.
While elevating intracellular c-di-GMP in C. difﬁcile increased
pilA1 transcript levels by 30 to 40-fold, c-di-GMP increased
Cdi2_4 riboswitch read-through transcription from 50% to 80%
in vitro. Yet, it is not uncommon to observe a relatively modest
change in transcription in single-round in vitro transcription as-
says compared to the observed cellular transcript levels (78–81).
As for other in vitro assays, single-round transcription assays pro-
vide clear evidence of a biological process, although the results
obtained may suffer from the inherent lack of complexity and/or
from inaccuracy compared to biological systems. Nonetheless, the
hypothesized transcriptional termination switch of riboswitch
Cdi2_4 conﬁrmed in vitro echoes recent unexplained results. Re-
cently, Soutourina et al. (32) have identiﬁed regulatory RNAs in
the whole genome of C. difﬁcile 630 and conﬁrmed the expression
of the 12 c-di-GMP-I and 4 c-di-GMP-II predicted riboswitches.
The authors reported increased pilA1 (CD3513) transcript levels
and observed only full-length transcripts upon increasing c-di-
GMP levels. They reasonably hypothesized that the full-length
transcripts were stabilized only under the condition of elevated
c-di-GMP because of active translation of PilA1, assuming that all
4 c-di-GMP-II riboswitches have the same expression platform as
Cdi2_1, which contains an 600-nt self-splicing group I intron
promoting translation of the CD3246 putative surface protein
upon binding of c-di-GMP to the aptamer (25, 82). However, this
self-splicing group I ribozyme is the only one among the 10 rep-
resentative ribozymes predicted in strain 630 to be located near a
c-di-GMP riboswitch (25). Although translation of the full-length
transcripts upon increasing c-di-GMP levels may still contribute
to pilA1 transcript stability, our results suggest that c-di-GMP
increases pilA1 transcript levels through binding to a transcrip-
tionally activating c-di-GMP riboswitch rather than by promoting
pilA1 translation.
The exact mechanism leading to T4P-dependent cell aggregation
and its role in the physiology and pathogenesis of C. difﬁcile remain
to be determined. It is reasonable to presume that T4P may also be
involved in other phenotypes in C. difﬁcile, such as bioﬁlm forma-
tion,whichwas recently reported tobe inducedby c-di-GMP(32).C.
difﬁcile cells can grow in vitro on abiotic surfaces embedded within a
bioﬁlm matrix containing exopolysaccharides, DNA, and proteins,
which increases resistance of vegetative cells to oxidative stress and
vancomycin (83, 84). Hypothetically, autoaggregation could pro-
mote bioﬁlm formation in its early stages. However, preliminary ex-
periments did not show a clear contribution of T4P or c-di-GMP to
bioﬁlmformation, as thephenotypewasweakandvariableunderour
experimental conditions. Bioﬁlm formation in C. difﬁcile was re-
ported tobeweakerwith strain 630 thanwith strainR20291 (84), and
perhaps the latter, and other strains, should be used in future studies
to ascertain the role of T4P in C. difﬁcile.
Nevertheless, we speculate that T4P are involved in the patho-
genicity of C. difﬁcile. Multicellular structures of C. difﬁcile cells,
described as cell aggregates, were observed in a mouse model of
colonization and suggest that aggregation and/or bioﬁlm could be
important for colonization (85). Goulding et al. (86) also detected
the presence of pilus-like structures at the surface of C. difﬁcile
cells within the intestinal crypts of infected hamsters and detected
the predicted pilin CD3507 in vivo. These observations and our
results conﬁrmed that T4P are produced at the cell surface and
suggest that these appendages are important for host colonization
and pathogenesis of C. difﬁcile.
ACKNOWLEDGMENTS
We thankRobertMcKee, AdamSpaulding, andAnkundaKariisa for their
assistance in enumerating pili for the electron microscopy studies and
Mihnea Mangalea for the construction of the sigD mutant.
This work was supported by a grant from the FRQNT Research Team
Control of Type IV Pilus Biogenesis in C. difﬁcile
March 2015 Volume 197 Number 5 jb.asm.org 829Journal of Bacteriology
RQ)HEUXDU\E\8
1
,9
(
5
6
,7(
'
(
6
+
(
5
%
5
2
2
.
(
KWWSMEDVP
RUJ
'
RZ
QORDGHGIURP

program toV.B. and L.-C.F., an Alexander GrahamBell CanadaGraduate
Scholarship from the NSERC to E.B., and NIH awards T32-DK007737 to
E.B.P. and U54-AI057157 and R01-AI107029 to R.T. V.B. holds a Canada
Research Chair in Bacterial Molecular Genetics.
The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
REFERENCES
1. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difﬁcile infec-
tion: new developments in epidemiology and pathogenesis. Nat Rev Mi-
crobiol 7:526–536. http://dx.doi.org/10.1038/nrmicro2164.
2. Giel JL, Sorg JA, Sonenshein AL, Zhu J. 2010. Metabolism of bile salts in
mice inﬂuences spore germination in Clostridium difﬁcile. PLoS One
5:e8740. http://dx.doi.org/10.1371/journal.pone.0008740.
3. Wilson KH, Sheagren JN, Freter R. 1985. Population dynamics of
ingested Clostridium difﬁcile in the gastrointestinal tract of the Syrian
hamster. J Infect Dis 151:355–361. http://dx.doi.org/10.1093/infdis/151.2
.355.
4. Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. 2007. Re-
pression of Clostridium difﬁcile toxin gene expression by CodY. Mol Mi-
crobiol 66:206–219. http://dx.doi.org/10.1111/j.1365-2958.2007.05906.x.
5. El Meouche I, Peltier J, Monot M, Soutourina O, Pestel-Caron M,
Dupuy B, Pons JL. 2013. Characterization of the SigD regulon of C.
difﬁcile and its positive control of toxin production through the regulation
of tcdR. PLoS One 8:e83748. http://dx.doi.org/10.1371/journal.pone
.0083748.
6. Ho TD, Ellermeier CD. 2011. PrsW is required for colonization, resis-
tance to antimicrobial peptides, and expression of extracytoplasmic func-
tion sigma factors in Clostridium difﬁcile. Infect Immun 79:3229–3238.
http://dx.doi.org/10.1128/IAI.00019-11.
7. Mani N, Dupuy B. 2001. Regulation of toxin synthesis in Clostridium
difﬁcile by an alternative RNApolymerase sigma factor. ProcNatl Acad Sci
U S A 98:5844–5849. http://dx.doi.org/10.1073/pnas.101126598.
8. Martin MJ, Clare S, Goulding D, Faulds-Pain A, Barquist L, Browne
HP, Pettit L, Dougan G, Lawley TD, Wren BW. 2013. The agr locus
regulates virulence and colonization genes in Clostridium difﬁcile 027. J
Bacteriol 195:3672–3681. http://dx.doi.org/10.1128/JB.00473-13.
9. Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I. 2011.
The key sigma factor of transition phase, SigH, controls sporulation, me-
tabolism, and virulence factor expression in Clostridium difﬁcile. J Bacte-
riol 193:3186–3196. http://dx.doi.org/10.1128/JB.00272-11.
10. Hengge R. 2009. Principles of c-di-GMP signalling in bacteria. Nat Rev
Microbiol 7:263–273. http://dx.doi.org/10.1038/nrmicro2109.
11. Römling U, Galperin MY, Gomelsky M. 2013. Cyclic di-GMP: the ﬁrst 25
years of a universal bacterial second messenger. Microbiol Mol Biol Rev
77:1–52. http://dx.doi.org/10.1128/MMBR.00043-12.
12. Tamayo R, Pratt JT, Camilli A. 2007. Roles of cyclic diguanylate in the
regulation of bacterial pathogenesis. Annu Rev Microbiol 61:131–148.
http://dx.doi.org/10.1146/annurev.micro.61.080706.093426.
13. Aldridge P, Paul R, Goymer P, Rainey P, Jenal U. 2003. Role of the
GGDEF regulator PleD in polar development of Caulobacter crescentus.
Mol Microbiol 47:1695–1708. http://dx.doi.org/10.1046/j.1365-2958
.2003.03401.x.
14. Tischler AD, Camilli A. 2005. Cyclic diguanylate regulates Vibrio cholerae
virulence gene expression. Infect Immun 73:5873–5882. http://dx.doi.org
/10.1128/IAI.73.9.5873-5882.2005.
15. Pitzer JE, Sultan SZ, Hayakawa Y, Hobbs G, Miller MR, Motaleb MA.
2011. Analysis of the Borrelia burgdorferi cyclic-di-GMP-binding protein
PlzA reveals a role in motility and virulence. Infect Immun 79:1815–1825.
http://dx.doi.org/10.1128/IAI.00075-11.
16. Kulasakara H, Lee V, Brencic A, Liberati N, Urbach J, Miyata S, Lee
DG, Neely AN, Hyodo M, Hayakawa Y, Ausubel FM, Lory S. 2006.
Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodi-
esterases reveals a role for bis-(3=-5=)-cyclic-GMP in virulence. Proc
Natl Acad Sci U S A 103:2839–2844. http://dx.doi.org/10.1073/pnas
.0511090103.
17. Ryan RP, Fouhy Y, Lucey JF, Crossman LC, Spiro S, He YW, Zhang LH,
Heeb S, Camara M, Williams P, Dow JM. 2006. Cell-cell signaling in
Xanthomonas campestris involves an HD-GYP domain protein that func-
tions in cyclic di-GMP turnover. ProcNatl Acad SciU SA 103:6712–6717.
http://dx.doi.org/10.1073/pnas.0600345103.
18. Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M. 2005. Cyclic
diguanylate is a ubiquitous signaling molecule in bacteria: insights into
biochemistry of the GGDEF protein domain. J Bacteriol 187:1792–1798.
http://dx.doi.org/10.1128/JB.187.5.1792-1798.2005.
19. Schmidt AJ, Ryjenkov DA, Gomelsky M. 2005. The ubiquitous protein
domain EAL is a cyclic diguanylate-speciﬁc phosphodiesterase: enzymat-
ically active and inactive EAL domains. J Bacteriol 187:4774–4781. http:
//dx.doi.org/10.1128/JB.187.14.4774-4781.2005.
20. Simm R, Morr M, Kader A, Nimtz M, Romling U. 2004. GGDEF and
EAL domains inversely regulate cyclic di-GMP levels and transition from
sessility to motility. Mol Microbiol 53:1123–1134. http://dx.doi.org/10
.1111/j.1365-2958.2004.04206.x.
21. Tamayo R, Tischler AD, Camilli A. 2005. The EAL domain protein VieA
is a cyclic diguanylate phosphodiesterase. J Biol Chem 280:33324–33330.
http://dx.doi.org/10.1074/jbc.M506500200.
22. Amikam D, Galperin MY. 2006. PilZ domain is part of the bacterial
c-di-GMP binding protein. Bioinformatics 22:3–6. http://dx.doi.org/10
.1093/bioinformatics/bti739.
23. Hickman JW, Harwood CS. 2008. Identiﬁcation of FleQ from Pseu-
domonas aeruginosa as a c-di-GMP-responsive transcription factor.
Mol Microbiol 69:376–389. http://dx.doi.org/10.1111/j.1365-2958.2008
.06281.x.
24. Krasteva PV, Fong JC, Shikuma NJ, Beyhan S, Navarro MV, Yildiz FH,
Sondermann H. 2010. Vibrio cholerae VpsT regulates matrix production
and motility by directly sensing cyclic di-GMP. Science 327:866–868.
http://dx.doi.org/10.1126/science.1181185.
25. Lee ER, Baker JL, Weinberg Z, Sudarsan N, Breaker RR. 2010. An
allosteric self-splicing ribozyme triggered by a bacterial secondmessenger.
Science 329:845–848. http://dx.doi.org/10.1126/science.1190713.
26. Sudarsan N, Lee ER, Weinberg Z, Moy RH, Kim JN, Link KH, Breaker RR.
2008. Riboswitches in eubacteria sense the second messenger cyclic di-GMP.
Science 321:411–413. http://dx.doi.org/10.1126/science.1159519.
27. Breaker RR. 2012. Riboswitches and the RNA world. Cold Spring Harb
Perspect Biol 4(2):a003566. http://dx.doi.org/10.1101/cshperspect
.a003566.
28. Serganov A, Nudler E. 2013. A decade of riboswitches. Cell 152:17–24.
http://dx.doi.org/10.1016/j.cell.2012.12.024.
29. Bordeleau E, Fortier LC, Malouin F, Burrus V. 2011. c-di-GMP turn-
over in Clostridium difﬁcile is controlled by a plethora of diguanylate cy-
clases and phosphodiesterases. PLoS Genet 7:e1002039. http://dx.doi.org
/10.1371/journal.pgen.1002039.
30. Gao X, Dong X, Subramanian S, Matthews PM, Cooper CA, Kearns
DB, Dann CE, III. 2014. Engineered Bacillus subtilis strains allow for
rapid characterization of heterologous diguanylate cyclases and phos-
phodiesterases. Appl Environ Microbiol 80:6167–6174. http://dx.doi.org
/10.1128/AEM.01638-14.
31. Purcell EB, McKee RW, McBride SM, Waters CM, Tamayo R. 2012.
Cyclic diguanylate inversely regulatesmotility and aggregation inClostrid-
ium difﬁcile. J Bacteriol 194:3307–3316. http://dx.doi.org/10.1128/JB
.00100-12.
32. Soutourina OA, Monot M, Boudry P, Saujet L, Pichon C, Sismeiro O,
Semenova E, Severinov K, Le Bouguenec C, Coppee JY, Dupuy B,
Martin-Verstraete I. 2013. Genome-wide identiﬁcation of regulatory
RNAs in the human pathogen Clostridium difﬁcile. PLoS Genet
9:e1003493. http://dx.doi.org/10.1371/journal.pgen.1003493.
33. Cafardi V, Biagini M, Martinelli M, Leuzzi R, Rubino JT, Cantini F,
Norais N, Scarselli M, Serruto D, Unnikrishnan M. 2013. Identiﬁcation
of a novel zinc metalloprotease through a global analysis of Clostridium
difﬁcile extracellular proteins. PLoS One 8:e81306. http://dx.doi.org/10
.1371/journal.pone.0081306.
34. Hensbergen PJ, Klychnikov OI, Bakker D, van Winden VJ, Ras N,
Kemp AC, Cordfunke RA, Dragan I, Deelder AM, Kuijper EJ, Corver J,
Drijfhout JW, van Leeuwen HC. 2014. A novel secreted metalloprotease
(CD2830) from Clostridium difﬁcile cleaves speciﬁc proline sequences in
LPXTG cell surface proteins. Mol Cell Proteomics 13:1231–1244. http:
//dx.doi.org/10.1074/mcp.M113.034728.
35. Giltner CL, Nguyen Y, Burrows LL. 2012. Type IV pilin proteins: versa-
tilemolecularmodules.MicrobiolMol Biol Rev 76:740–772. http://dx.doi
.org/10.1128/MMBR.00035-12.
36. Proft T, Baker EN. 2009. Pili in Gram-negative and Gram-positive bac-
teria—structure, assembly and their role in disease. Cell Mol Life Sci 66:
613–635. http://dx.doi.org/10.1007/s00018-008-8477-4.
37. Craig L, Li J. 2008. Type IV pili: paradoxes in form and function. Curr
Opin Struct Biol 18:267–277. http://dx.doi.org/10.1016/j.sbi.2007.12.009.
Bordeleau et al.
830 jb.asm.org March 2015 Volume 197 Number 5Journal of Bacteriology
RQ)HEUXDU\E\8
1
,9
(
5
6
,7(
'
(
6
+
(
5
%
5
2
2
.
(
KWWSMEDVP
RUJ
'
RZ
QORDGHGIURP

38. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler
R, Thomson NR, Roberts AP, Cerdeno-Tarraga AM, Wang H, Holden
MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K,
Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T,
Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbin-
owitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S,
Dupuy B, Dougan G, Barrell B, Parkhill J. 2006. The multidrug-resistant
human pathogenClostridiumdifﬁcile has a highlymobile,mosaic genome.
Nat Genet 38:779–786. http://dx.doi.org/10.1038/ng1830.
39. Varga JJ, Nguyen V, O’Brien DK, Rodgers K, Walker RA, Melville SB.
2006. Type IV pili-dependent glidingmotility in theGram-positive patho-
gen Clostridium perfringens and other Clostridia. Mol Microbiol 62:680–
694. http://dx.doi.org/10.1111/j.1365-2958.2006.05414.x.
40. Imam S, Chen Z, Roos DS, Pohlschroder M. 2011. Identiﬁcation of
surprisingly diverse type IV pili, across a broad range of Gram-positive
bacteria. PLoS One 6:e28919. http://dx.doi.org/10.1371/journal.pone
.0028919.
41. Melville S, Craig L. 2013. Type IV pili in Gram-positive bacteria.
Microbiol Mol Biol Rev 77:323–341. http://dx.doi.org/10.1128
/MMBR.00063-12.
42. Maldarelli GA, De Masi L, von Rosenvinge EC, Carter M, Donnenberg
MS. 2014. Identiﬁcation, immunogenicity, and cross-reactivity of type IV
pilin and pilin-like proteins from Clostridium difﬁcile. Pathog Dis 71:302–
314. http://dx.doi.org/10.1111/2049-632X.12137.
43. Smith CJ, Markowitz SM, Macrina FL. 1981. Transferable tetracycline
resistance in Clostridium difﬁcile. Antimicrob Agents Chemother 19:997–
1003. http://dx.doi.org/10.1128/AAC.19.6.997.
44. Karberg M, Guo H, Zhong J, Coon R, Perutka J, Lambowitz AM. 2001.
Group II introns as controllable gene targeting vectors for genetic manip-
ulation of bacteria. Nat Biotechnol 19:1162–1167. http://dx.doi.org/10
.1038/nbt1201-1162.
45. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC,
Minton NP. 2010. The ClosTron: mutagenesis in Clostridium reﬁned and
streamlined. J Microbiol Methods 80:49–55. http://dx.doi.org/10.1016/j
.mimet.2009.10.018.
46. Perutka J, Wang W, Goerlitz D, Lambowitz AM. 2004. Use of computer-
designed group II introns to disrupt Escherichia coli DExH/D-box protein
and DNA helicase genes. J Mol Biol 336:421–439. http://dx.doi.org/10
.1016/j.jmb.2003.12.009.
47. Heap JT, Cartman ST, Kuehne SA, Cooksley C, Minton NP. 2010.
ClosTron-targeted mutagenesis. Methods Mol Biol 646:165–182. http:
//dx.doi.org/10.1007/978-1-60327-365-7_11.
48. Bouillaut L, Self WT, Sonenshein AL. 2013. Proline-dependent regula-
tion of Clostridium difﬁcile Stickland metabolism. J Bacteriol 195:844–
854. http://dx.doi.org/10.1128/JB.01492-12.
49. Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL. 1995.
Single-step assembly of a gene and entire plasmid from large numbers of
oligodeoxyribonucleotides. Gene 164:49–53. http://dx.doi.org/10.1016
/0378-1119(95)00511-4.
50. Colmin C, Pebay M, Simonet JM, Decaris B. 1991. A species-speciﬁc
DNA probe obtained from Streptococcus salivarius subsp. thermophilus
detects strain restriction polymorphismFEMSMicrobiol Lett 65:123–128.
51. Dower WJ, Miller JF, Ragsdale CW. 1988. High efﬁciency transforma-
tion of E. coli by high voltage electroporation. Nucleic Acids Res 16:6127–
6145. http://dx.doi.org/10.1093/nar/16.13.6127.
52. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J.
2007. qBase relative quantiﬁcation framework and software for manage-
ment and automated analysis of real-time quantitative PCR data. Genome
Biol 8:R19. http://dx.doi.org/10.1186/gb-2007-8-2-r19.
53. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe
A, Speleman F. 2002. Accurate normalization of real-time quantitative
RT-PCR data by geometric averaging of multiple internal control genes.
Genome Biol 3:RESEARCH0034. http://dx.doi.org/10.1186/gb-2002-3-7
-research0034.
54. Brosseau JP, Lucier JF, Lapointe E, Durand M, Gendron D, Gervais-
Bird J, Tremblay K, Perreault JP, Elela SA. 2010. High-throughput
quantiﬁcation of splicing isoforms. RNA 16:442–449. http://dx.doi.org
/10.1261/rna.1877010.
55. Blouin S, Lafontaine DA. 2007. A loop loop interaction and a K-turn
motif located in the lysine aptamer domain are important for the ribo-
switch gene regulation control. RNA 13:1256–1267. http://dx.doi.org/10
.1261/rna.560307.
56. Pleiss JA, Derrick ML, Uhlenbeck OC. 1998. T7 RNA polymerase produces
5= end heterogeneity during in vitro transcription from certain templates.
RNA 4:1313–1317. http://dx.doi.org/10.1017/S135583829800106X.
57. Freitag NE, Seifert HS, Koomey M. 1995. Characterization of the pilF-
pilDpilus-assembly locus ofNeisseria gonorrhoeae.MolMicrobiol 16:575–
586. http://dx.doi.org/10.1111/j.1365-2958.1995.tb02420.x.
58. Turner LR, Lara JC, Nunn DN, Lory S. 1993. Mutations in the consensus
ATP-binding sites of XcpR and PilB eliminate extracellular protein secre-
tion and pilus biogenesis in Pseudomonas aeruginosa. J Bacteriol 175:
4962–4969.
59. Aubry A, Hussack G, Chen W, KuoLee R, Twine SM, Fulton KM, Foote
S, Carrillo CD, Tanha J, Logan SM. 2012. Modulation of toxin produc-
tion by the ﬂagellar regulon in Clostridium difﬁcile. Infect Immun 80:
3521–3532. http://dx.doi.org/10.1128/IAI.00224-12.
60. Strom MS, Lory S. 1991. Amino acid substitutions in pilin of Pseudomo-
nas aeruginosa. Effect on leader peptide cleavage, amino-terminal meth-
ylation, and pilus assembly. J Biol Chem 266:1656–1664.
61. Mitra A, Kesarwani AK, Pal D, Nagaraja V. 2011. WebGeSTer DB—a
transcription terminator database. Nucleic Acids Res 39:D129–D135.
http://dx.doi.org/10.1093/nar/gkq971.
62. Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. 2008. The
Vienna RNAwebsuite. Nucleic Acids Res 36:W70–W74. http://dx.doi.org
/10.1093/nar/gkn188.
63. Wickiser JK, Winkler WC, Breaker RR, Crothers DM. 2005. The speed
of RNA transcription and metabolite binding kinetics operate an FMN
riboswitch. Mol Cell 18:49–60. http://dx.doi.org/10.1016/j.molcel.2005
.02.032.
64. Smith KD, Shanahan CA, Moore EL, Simon AC, Strobel SA. 2011.
Structural basis of differential ligand recognition by two classes of bis-(3=-
5=)-cyclic dimeric guanosine monophosphate-binding riboswitches. Proc
Natl Acad Sci U S A 108:7757–7762. http://dx.doi.org/10.1073/pnas
.1018857108.
65. Rakotoarivonina H, Jubelin G, Hebraud M, Gaillard-Martinie B,
Forano E, Mosoni P. 2002. Adhesion to cellulose of the Gram-positive
bacterium Ruminococcus albus involves type IV pili. Microbiology 148:
1871–1880.
66. Varga JJ, Therit B, Melville SB. 2008. Type IV pili and the CcpA protein
are needed for maximal bioﬁlm formation by the Gram-positive anaero-
bic pathogen Clostridium perfringens. Infect Immun 76:4944–4951. http:
//dx.doi.org/10.1128/IAI.00692-08.
67. Borriello SP, Davies HA, Barclay FE. 1988. Detection of ﬁmbriae
amongst strains of Clostridium difﬁcile. FEMS Microbiol Lett 49:65–67.
http://dx.doi.org/10.1111/j.1574-6968.1988.tb02683.x.
68. Piepenbrink KH, Maldarelli GA, de la Pena CF, Mulvey GL, Snyder GA,
De Masi L, von Rosenvinge EC, Gunther S, Armstrong GD, Donnen-
berg MS, Sundberg EJ. 2014. Structure of Clostridium difﬁcile PilJ exhibits
unprecedented divergence from known type IV pilins. J Biol Chem 289:
4334–4345. http://dx.doi.org/10.1074/jbc.M113.534404.
69. Giltner CL, Habash M, Burrows LL. 2010. Pseudomonas aeruginosa
minor pilins are incorporated into type IV pili. J Mol Biol 398:444–461.
http://dx.doi.org/10.1016/j.jmb.2010.03.028.
70. Nair DB, Chung DK, Schneider J, Uchida K, Aizawa S, Jarrell KF. 2013.
Identiﬁcation of an additional minor pilin essential for piliation in the
archaeon Methanococcus maripaludis. PLoS One 8:e83961. http://dx.doi
.org/10.1371/journal.pone.0083961.
71. Winther-Larsen HC, Wolfgang M, Dunham S, van Putten JP, Dorward
D, Lovold C, Aas FE, Koomey M. 2005. A conserved set of pilin-like
molecules controls type IV pilus dynamics and organelle-associated func-
tions in Neisseria gonorrhoeae. Mol Microbiol 56:903–917. http://dx.doi
.org/10.1111/j.1365-2958.2005.04591.x.
72. Alm RA, Bodero AJ, Free PD, Mattick JS. 1996. Identiﬁcation of a novel
gene, pilZ, essential for type 4 ﬁmbrial biogenesis in Pseudomonas aerugi-
nosa. J Bacteriol 178:46–53.
73. Merighi M, Lee VT, Hyodo M, Hayakawa Y, Lory S. 2007. The second
messenger bis-(3=-5=)-cyclic-GMP and its PilZ domain-containing recep-
tor Alg44 are required for alginate biosynthesis in Pseudomonas aerugi-
nosa. Mol Microbiol 65:876–895. http://dx.doi.org/10.1111/j.1365-2958
.2007.05817.x.
74. Huang B, Whitchurch CB, Mattick JS. 2003. FimX, a multidomain
protein connecting environmental signals to twitching motility in Pseu-
domonas aeruginosa. J Bacteriol 185:7068–7076. http://dx.doi.org/10
.1128/JB.185.24.7068-7076.2003.
75. Jain R, Behrens AJ, Kaever V, Kazmierczak BI. 2012. Type IV pilus
assembly in Pseudomonas aeruginosa over a broad range of cyclic di-GMP
Control of Type IV Pilus Biogenesis in C. difﬁcile
March 2015 Volume 197 Number 5 jb.asm.org 831Journal of Bacteriology
RQ)HEUXDU\E\8
1
,9
(
5
6
,7(
'
(
6
+
(
5
%
5
2
2
.
(
KWWSMEDVP
RUJ
'
RZ
QORDGHGIURP

concentrations. J Bacteriol 194:4285–4294. http://dx.doi.org/10.1128/JB
.00803-12.
76. Kazmierczak BI, Lebron MB, Murray TS. 2006. Analysis of FimX, a
phosphodiesterase that governs twitchingmotility inPseudomonas aerugi-
nosa. Mol Microbiol 60:1026–1043. http://dx.doi.org/10.1111/j.1365
-2958.2006.05156.x.
77. Guzzo CR, Salinas RK, Andrade MO, Farah CS. 2009. PILZ protein
structure and interactions with PILB and the FIMX EAL domain: impli-
cations for control of type IV pilus biogenesis. J Mol Biol 393:848–866.
http://dx.doi.org/10.1016/j.jmb.2009.07.065.
78. Lemay JF, Penedo JC, Tremblay R, Lilley DM, Lafontaine DA. 2006.
Folding of the adenine riboswitch. Chem Biol 13:857–868. http://dx.doi
.org/10.1016/j.chembiol.2006.06.010.
79. Lemay JF, Desnoyers G, Blouin S, Heppell B, Bastet L, St-Pierre P,
Masse E, Lafontaine DA. 2011. Comparative study between transcrip-
tionally- and translationally-acting adenine riboswitches reveals key dif-
ferences in riboswitch regulatory mechanisms. PLoS Genet 7:e1001278.
http://dx.doi.org/10.1371/journal.pgen.1001278.
80. Heppell B, Blouin S, Dussault AM, Mulhbacher J, Ennifar E, Penedo
JC, Lafontaine DA. 2011. Molecular insights into the ligand-controlled
organization of the SAM-I riboswitch. Nat Chem Biol 7:384–392. http:
//dx.doi.org/10.1038/nchembio.563.
81. Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR. 2003. An
mRNA structure that controls gene expression by binding S-
adenosylmethionine. Nat Struct Biol 10:701–707. http://dx.doi.org/10
.1038/nsb967.
82. Chen AG, Sudarsan N, Breaker RR. 2011. Mechanism for gene control by
a natural allosteric group I ribozyme. RNA 17:1967–1972. http://dx.doi
.org/10.1261/rna.2757311.
83. Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW. 2012.
Characterisation of Clostridium difﬁcile bioﬁlm formation, a role for
Spo0A. PLoS One 7:e50527. http://dx.doi.org/10.1371/journal.pone
.0050527.
84. Dapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M,
Minton NP, Serruto D, Unnikrishnan M. 2013. Multiple factors modu-
late bioﬁlm formation by the anaerobic pathogen Clostridium difﬁcile. J
Bacteriol 195:545–555. http://dx.doi.org/10.1128/JB.01980-12.
85. Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N,
Mastroeni P, Scott P, Raisen C, Mottram L, Fairweather NF, Wren BW,
Parkhill J, Dougan G. 2009. Antibiotic treatment of Clostridium difﬁcile
carrier mice triggers a supershedder state, spore-mediated transmission,
and severe disease in immunocompromised hosts. Infect Immun 77:
3661–3669. http://dx.doi.org/10.1128/IAI.00558-09.
86. Goulding D, Thompson H, Emerson J, Fairweather NF, Dougan G,
Douce GR. 2009. Distinctive proﬁles of infection and pathology in ham-
sters infected with Clostridium difﬁcile strains 630 and B1. Infect Immun
77:5478–5485. http://dx.doi.org/10.1128/IAI.00551-09.
87. Hussain HA, Roberts AP, Mullany P. 2005. Generation of an erythro-
mycin-sensitive derivative of Clostridium difﬁcile strain 630 (630erm)
and demonstration that the conjugative transposon Tn916E enters the
genome of this strain at multiple sites. J Med Microbiol 54:137–141. http:
//dx.doi.org/10.1099/jmm.0.45790-0.
88. Purdy D, O’Keeffe TA, Elmore M, Herbert M, McLeod A, Bokori-
Brown M, Ostrowski A, Minton NP. 2002. Conjugative transfer of clos-
tridial shuttle vectors from Escherichia coli to Clostridium difﬁcile through
circumvention of the restriction barrier.MolMicrobiol 46:439–452. http:
//dx.doi.org/10.1046/j.1365-2958.2002.03134.x.
89. Leontis NB, Westhof E. 2001. Geometric nomenclature and classiﬁ-
cation of RNA base pairs. RNA 7:499–512. http://dx.doi.org/10.1017
/S1355838201002515.
Bordeleau et al.
832 jb.asm.org March 2015 Volume 197 Number 5Journal of Bacteriology
RQ)HEUXDU\E\8
1
,9
(
5
6
,7(
'
(
6
+
(
5
%
5
2
2
.
(
KWWSMEDVP
RUJ
'
RZ
QORDGHGIURP

